DK1905775T3 - Tetracykliske forbindelser, fremgangsmåder til at fremstille disse, farmaceutiske sammensætninger indeholdende disse og anvendelse heraf som dopaminreceptorligander - Google Patents
Tetracykliske forbindelser, fremgangsmåder til at fremstille disse, farmaceutiske sammensætninger indeholdende disse og anvendelse heraf som dopaminreceptorliganderInfo
- Publication number
- DK1905775T3 DK1905775T3 DK07291135.7T DK07291135T DK1905775T3 DK 1905775 T3 DK1905775 T3 DK 1905775T3 DK 07291135 T DK07291135 T DK 07291135T DK 1905775 T3 DK1905775 T3 DK 1905775T3
- Authority
- DK
- Denmark
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- compositions containing
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0608413A FR2906249B1 (fr) | 2006-09-26 | 2006-09-26 | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1905775T3 true DK1905775T3 (da) | 2010-12-06 |
Family
ID=37877016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07291135.7T DK1905775T3 (da) | 2006-09-26 | 2007-09-25 | Tetracykliske forbindelser, fremgangsmåder til at fremstille disse, farmaceutiske sammensætninger indeholdende disse og anvendelse heraf som dopaminreceptorligander |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7470683B2 (da) |
| EP (1) | EP1905775B1 (da) |
| JP (1) | JP2008100995A (da) |
| KR (1) | KR100934315B1 (da) |
| CN (1) | CN101153043B (da) |
| AR (1) | AR062950A1 (da) |
| AT (1) | ATE480544T1 (da) |
| AU (1) | AU2007219281A1 (da) |
| BR (1) | BRPI0703655A2 (da) |
| CA (1) | CA2603274C (da) |
| CY (1) | CY1110799T1 (da) |
| DE (1) | DE602007009004D1 (da) |
| DK (1) | DK1905775T3 (da) |
| EA (1) | EA013406B1 (da) |
| ES (1) | ES2351945T3 (da) |
| FR (1) | FR2906249B1 (da) |
| GE (1) | GEP20104877B (da) |
| HR (1) | HRP20100605T1 (da) |
| MA (1) | MA29371B1 (da) |
| MX (1) | MX2007011524A (da) |
| MY (1) | MY142517A (da) |
| NO (1) | NO20074889L (da) |
| NZ (1) | NZ561905A (da) |
| PL (1) | PL1905775T3 (da) |
| PT (1) | PT1905775E (da) |
| RS (1) | RS51418B (da) |
| SG (1) | SG141382A1 (da) |
| SI (1) | SI1905775T1 (da) |
| UA (1) | UA96125C2 (da) |
| WO (1) | WO2008037888A2 (da) |
| ZA (1) | ZA200708215B (da) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
| CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
| FR2721027B1 (fr) | 1994-06-08 | 1996-07-19 | Adir | Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| FR2741074B1 (fr) | 1995-11-09 | 1997-12-19 | Adir | Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2767825A1 (fr) * | 1997-09-01 | 1999-02-26 | Adir | Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2845994B1 (fr) * | 2002-10-18 | 2006-05-19 | Servier Lab | Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2006
- 2006-09-26 FR FR0608413A patent/FR2906249B1/fr not_active Expired - Fee Related
-
2007
- 2007-09-11 MA MA30219A patent/MA29371B1/fr unknown
- 2007-09-19 MX MX2007011524A patent/MX2007011524A/es unknown
- 2007-09-21 KR KR1020070096525A patent/KR100934315B1/ko not_active Expired - Fee Related
- 2007-09-24 EA EA200701807A patent/EA013406B1/ru not_active IP Right Cessation
- 2007-09-24 CN CN2007101617348A patent/CN101153043B/zh not_active Expired - Fee Related
- 2007-09-24 AU AU2007219281A patent/AU2007219281A1/en not_active Abandoned
- 2007-09-24 SG SG200708582-2A patent/SG141382A1/en unknown
- 2007-09-24 AR ARP070104197A patent/AR062950A1/es unknown
- 2007-09-25 DK DK07291135.7T patent/DK1905775T3/da active
- 2007-09-25 ES ES07291135T patent/ES2351945T3/es active Active
- 2007-09-25 PL PL07291135T patent/PL1905775T3/pl unknown
- 2007-09-25 NZ NZ561905A patent/NZ561905A/en not_active IP Right Cessation
- 2007-09-25 GE GEAP200710284A patent/GEP20104877B/en unknown
- 2007-09-25 DE DE602007009004T patent/DE602007009004D1/de active Active
- 2007-09-25 EP EP07291135A patent/EP1905775B1/fr active Active
- 2007-09-25 RS RSP-2010/0420A patent/RS51418B/sr unknown
- 2007-09-25 WO PCT/FR2007/001557 patent/WO2008037888A2/fr not_active Ceased
- 2007-09-25 MY MYPI20071605A patent/MY142517A/en unknown
- 2007-09-25 AT AT07291135T patent/ATE480544T1/de active
- 2007-09-25 SI SI200730350T patent/SI1905775T1/sl unknown
- 2007-09-25 PT PT07291135T patent/PT1905775E/pt unknown
- 2007-09-25 US US11/904,006 patent/US7470683B2/en not_active Expired - Fee Related
- 2007-09-26 ZA ZA200708215A patent/ZA200708215B/xx unknown
- 2007-09-26 NO NO20074889A patent/NO20074889L/no not_active Application Discontinuation
- 2007-09-26 UA UAA200710656A patent/UA96125C2/ru unknown
- 2007-09-26 CA CA2603274A patent/CA2603274C/fr not_active Expired - Fee Related
- 2007-09-26 JP JP2007248428A patent/JP2008100995A/ja not_active Ceased
- 2007-09-26 BR BRPI0703655-8A patent/BRPI0703655A2/pt not_active IP Right Cessation
-
2010
- 2010-09-24 CY CY20101100862T patent/CY1110799T1/el unknown
- 2010-11-10 HR HR20100605T patent/HRP20100605T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1845978T3 (da) | Substituerede pyrazolopyridiner, sammensætninger, som indeholder disse, fremgangsmåde til fremstilling heraf, og anvendelse heraf | |
| DK2036892T3 (da) | 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| IL205360A0 (en) | Methods, kits, and compositions for administering pharmaceutical compounds | |
| DK2063940T3 (da) | Inhalationsapparat til lægemidler i pulverform | |
| PL2317852T3 (pl) | Preparaty farmaceutyczne zawierające ligandy receptora dopaminy | |
| DK2107055T3 (da) | Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK2029549T3 (da) | Phenyl-pyrazol-derivater som ikke-steroide glucocoricoid-receptorligander | |
| ZA200808530B (en) | Pharmaceutical composition for external use | |
| SI2079688T1 (sl) | Spojine glukagon receptorskih antagonistov, sestavki vsebujoči take spojine in njihova farmacevtska raba | |
| DK2004654T3 (da) | Pyrazolopyrimidin derivater til anvendelse som kinase antagonister | |
| ZA200808531B (en) | Pharmaceutical composition for external use | |
| DK2344198T3 (da) | Lipidbaserede farmaceutiske præparater til topisk anvendelse | |
| DK3984528T3 (da) | Farmaceutiske sammensætninger, som omfatter nilotinib | |
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| DK2254549T4 (da) | Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser | |
| DK2245026T3 (da) | Spirocycliske heterocycler, lægemiddel indeholdende disse forbindelser, deres anvendelse og fremgangsmåde til deres fremstilling | |
| DK2038294T3 (da) | 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-oner) og farmaceutiske præparater, der indeholder disse | |
| NO20090724L (no) | Benzylaminer, fremgangsmåte for fremstilling av slike, og anvendelse av dem som betennelseshemmende midler | |
| DK2281822T3 (da) | Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
| FI20041129A0 (fi) | Tioksotiatsolidinoniyhdisteitä lääkkeinä käytettäviksi | |
| EP2201011A4 (en) | NEW COMPOUNDS WITH INDAZOUS OUTS, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| DK2132185T3 (da) | Pyrimidinyl-piperaziner nyttige som dopamin-D3/D2-receptorligander | |
| DK2231598T3 (da) | Nye diazeniumdiolatderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK2147915T3 (da) | Nye cycloalkylerede benzothiadiazinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |